/Insulet%20Corporation%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
With a market cap of $13.5 billion, Massachusetts-based Insulet Corporation (PODD) operates in the healthcare sector and specializes in insulin delivery systems. The company's flagship Omnipod platform, including the Omnipod 5 and Omnipod DASH systems, offers innovative, tubeless insulin delivery solutions for people with insulin-dependent diabetes.
Shares of this insulin infusion systems maker have underperformed the broader market over the past 52 weeks. PODD has risen 5.2% over this time frame, while the broader S&P 500 Index ($SPX) has gained 27.7%. In 2024, PODD stock declined 11.3%, compared to SPX's nearly 18% YTD gain.